The Epidemic Within the Pandemic: Managing Complications in Populations with Obesity
Premiere Date: Wednesday, June 30, 2021This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, June 30, 2022
Note: Credit Is No Longer Available
 | Robert F. Kushner, MD, MS, DABOM (Moderator) Professor, Departments of Medicine and Medical Education Northwestern University Feinberg School of Medicine Chicago, IL |
 | Ken Fujioka, MD Director, Nutrition and Metabolic Research Center Founding Director, Center for Weight Management Scripps Clinic Department of Diabetes and Endocrine San Diego, CA |
 | Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS (she/her/hers) Associate Professor of Medicine and Pediatrics Obesity Medicine Physician Scientist Massachusetts General Hospital Boston, MA |
Obesity is increasingly recognized as a multi-causal chronic disease that leads to structural and physiological abnormalities and functional impairments. Despite the growing prevalence and substantial burden of obesity in terms of health-related quality of life (HRQoL), healthcare utilization, and healthcare costs, obesity remains under-diagnosed and under-treated. The recent recognition that obesity is associated with increased risk of morbidity and mortality with coronavirus disease 2019 (COVID-19) shines a light on the fact that obesity is characterized by higher prevalence of physiologic alterations, such as chronic inflammation and impaired respiratory function, when compared to the non-obese state.
This live and OnDemand webcast will include interactive animated 3-D models, and a live Q&A session. The discussion, led by expert faculty, will cover pathophysiological features of obesity that influence weight loss, guidelines for screening, diagnosis, and patient counseling, and how to assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.
At the end of this CE activity, participants should be able to:
- Identify pathophysiological features of obesity that influence weight loss and maintenance.
- Apply guidelines for screening, diagnosis, and patient counseling for obesity and obesity-related disorders.
- Assess efficacy and safety of available and emerging therapies for long-term treatment of obesity.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Identify pathophysiological features of obesity that influence weight loss and maintenance.
- Summarize guidelines for screening, diagnosis, and patient counseling for obesity and obesity-related disorders.
- Describe the efficacy and safety of available and emerging therapies for long-term treatment of obesity.
Supported by an educational grant from Novo Nordisk Inc.
Primary care physicians, endocrinologists, nurse practitioners, PAs, nurses, and pharmacists
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
Enduring: JA0007185-0000-21-125-H01-P
Type: Knowledge-based
ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Enduring material
Note to PAs: PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Royal College MOC: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME's "CME in Support of MOC" program in Section 3 of the Royal College's MOC Program.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kushner reports that he receives research support from Epitomee Medical. He is a consultant for Novo Nordisk and WW International, Inc.
Dr. Fujioka reports that he is a consultant for Amgen Inc.; Boehringer Ingelheim; Gelesis; Janssen Global Services, LLC; Novo Nordisk; Phenomix Sciences; Sunovion Pharmaceuticals Inc.; and Takeda Pharmaceuticals U.S.A., Inc. He is on the speakers bureau for Novo Nordisk and Takeda Pharmaceuticals U.S.A., Inc.
Dr. Stanford reports that she receives research support from Amazon. She is a consultant for Calibrate Health, Chroma Health, GoodRx, Inc., and Novo Nordisk.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Warren Beckman (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
TV-134-063021-68
